Drug Shortage Report for BREVICON 1/35 TABLETS (21-DAY PACK)

Last updated on 2021-02-02 History
Report ID 119179
Drug Identification Number 02189054
Brand name BREVICON 1/35 TABLETS (21-DAY PACK)
Common or Proper name BREVICON 21
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) NORETHINDRONE ETHINYL ESTRADIOL
Strength(s) 1MG 0.035MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 21's
ATC code G03AA
ATC description HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-06-29
Estimated end date 2021-02-01
Actual end date 2021-02-01
Shortage status Resolved
Updated date 2021-02-02
Company comments Recovery expected during Feb 2021.
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2021-02-02 French Compare
v10 2021-02-02 English Compare
v9 2021-01-15 French Compare
v8 2021-01-15 English Compare
v7 2020-09-18 French Compare
v6 2020-09-18 English Compare
v5 2020-07-13 French Compare
v4 2020-07-13 English Compare
v3 2020-06-30 English Compare
v2 2020-06-29 French Compare
v1 2020-06-29 English Compare

Showing 1 to 11 of 11